USPTO Examiner XU XIAOYUN - Art Unit 1797

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19196566IDENTIFICATION OF METABOLITES FOR DIAGNOSIS AND TREATMENT FOR SLEEP APNEAMay 2025June 2025Allow200NoNo
19063118SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSESFebruary 2025August 2025Allow610YesNo
19026954SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICEJanuary 2025April 2025Allow300NoNo
19013863METHODS FOR DETECTING AAVJanuary 2025March 2025Allow300NoNo
18957846URINE TEST DEVICE FOR TOILET AND ITS CONTROL METHODNovember 2024September 2025Abandon910NoNo
18948248SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSESNovember 2024December 2024Allow100YesNo
18894924HYDROGEL PARTICLES AS FEEDER CELLS AND AS SYNTHETIC ANTIGEN PRESENTING CELLSSeptember 2024April 2025Allow720YesNo
18841398METHOD FOR SYNCHRONOUS AND FAST DETERMINATION OF TOTAL ARSENIC AND CONTENTS OF ARSENIC METABOLITES IN URINEAugust 2024August 2025Abandon1210NoNo
18768028LUMINESCENT PROBE AND ITS PREPARATION METHOD AND APPLICATIONJuly 2024February 2025Allow811NoNo
18750532LIQUID CHROMATOGRAPHY- MASS SPECTROMETRY (LC-MS) METHODS FOR ANALYZING AMPHOLYTE LOT VARIATIONJune 2024February 2025Allow800YesNo
18737836PSEUDO-ELECTROPHEROGRAM CONSTRUCTION FROM PEPTIDE LEVEL MASS SPECTROMETRY DATAJune 2024February 2025Allow900NoNo
18646572SYSTEMS AND METHODS FOR GENERATING DROPLETS AND PERFORMING DIGITAL ANALYSESApril 2024December 2024Allow800YesNo
18644592REAGENTS AND METHODS FOR ELEMENTAL MASS SPECTROMETRY OF BIOLOGICAL SAMPLESApril 2024February 2025Allow1010NoNo
18641661Method for full Os isotope static measurement at low-content/small-size sampleApril 2024February 2025Allow1000NoNo
18698885HIGH TEMPERATURE HIGH PRESSURE ASPHALTENE DEPOSITION/INHIBITOR SCREENING TESTApril 2024August 2024Allow410YesNo
18615536Method and System for Solventless Calibration of Volatile or Semi-Volatile CompoundsMarch 2024December 2024Allow910NoNo
18606701SYSTEM AND METHOD FOR PROTEIN CORONA SENSOR ARRAY FOR EARLY DETECTION OF DISEASESMarch 2024October 2024Allow700NoNo
18691905METHOD FOR INCREASING NUMBER OF PROTEINS IDENTIFIED BY MASS SPECTROMETRYMarch 2024January 2025Allow1020YesNo
18603030DETERMINISTIC RATCHET FOR SUB-MICROMETER BIOPARTICLE SEPARATIONMarch 2024August 2025Abandon1720YesNo
18590471NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBESFebruary 2024November 2024Allow810NoNo
18417986SYNTHETIC HUMAN CELL MIMIC PARTICLE FOR CYTOMETRIC OR COULTER DEVICEJanuary 2024April 2024Allow300NoNo
18543524DETERMINATION OF ANTIDEPRESSANTS BY MASS SPECTROMETRYDecember 2023July 2025Allow1930YesNo
18514204APPARATUS AND METHODS FOR SAMPLE ACQUISITIONNovember 2023March 2025Allow1600NoNo
18388047CAPILLARY BARRIERS FOR STAGED LOADING OF MICROFLUIDIC DEVICESNovember 2023April 2025Allow1711YesNo
18386107HYDROGEL PARTICLES AS FEEDER CELLS AND AS SYNTHETIC ANTIGEN PRESENTING CELLSNovember 2023August 2024Allow921YesNo
18496681LIGHT ENERGY FLUORESCENCE EXCITATIONOctober 2023September 2025Allow2331YesYes
18491399INLET INSTRUMENTATION FOR ION ANALYSER COUPLED TO RAPID EVAPORATIVE IONISATION MASS SPECTROMETRY ("REIMS") DEVICEOctober 2023January 2026Abandon2720NoNo
18380961Method for Monitoring and Control of a Wastewater Process StreamOctober 2023August 2025Allow2220YesNo
18487393CONDENSED POLYCYCLIC CONJUGATED POLYMERS AND THEIR USE FOR BIOLOGICAL DETECTIONOctober 2023January 2025Allow1520NoNo
18477728SIMPLIFIED BIOSAMPLE PROCESSING FOR LC-MS/MSSeptember 2023June 2025Abandon2110NoNo
18474008HYDROGEN-BONDED ORGANIC FRAMEWORK NANOSHEET, PREPARATION METHOD AND APPLICATION THEREOFSeptember 2023November 2023Allow200NoNo
18471497System and Method for Background Removal in Spectrometry SystemSeptember 2023March 2026Abandon3020YesNo
18471025METHYLATION MARKERS AND TARGETED METHYLATION PROBE PANELSeptember 2023May 2025Allow1900NoNo
18465669MULTIFUNCTIONAL MAGNETIC TAGS FOR MUD LOGGINGSeptember 2023March 2025Allow1800NoNo
18241381DETECTION AND QUANTIFICATION OF GLYCOSYLATED PEPTIDESSeptember 2023August 2024Allow1200NoNo
18460474COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS AND USES THEREOFSeptember 2023December 2024Allow1640YesNo
18454838METHOD TO ANALYZE COMPOUNDS IN BIOLOGICAL SAMPLESAugust 2023July 2024Allow1100YesNo
18454159BIOMARKERS FOR DIAGNOSING NON-ALCOHOLIC STEATOHEPATITIS (NASH) OR HEPATOCELLULAR CARCINOMA (HCC)August 2023November 2024Allow1410NoNo
18235941METHOD FOR ANALYZING MICROORGANISMAugust 2023February 2026Allow3020YesNo
18235943METHOD FOR ANALYZING MICROORGANISMAugust 2023September 2024Allow1300NoNo
18236144METHOD OF SAMPLE PREPARATION FOR MALDI AND AUTOMATED SYSTEM THEREFORAugust 2023August 2024Allow1200YesNo
18546137MALDI-MS METHOD, PHOTO-SENSITIVE MALDI MATRIX COMPOSITE AND PHOTO-CAGED MALDI MATRIX COMPOUND FOR USE IN SAID METHOD AND RESPECTIVE USESAugust 2023February 2026Allow3000NoNo
18209074SYNCHRONIZATION OF ION GENERATION WITH CYCLING OF A DISCONTINUOUS ATMOSPHERIC INTERFACEJune 2023January 2025Allow1910NoNo
18208116SYSTEMS AND METHODS FOR SAMPLE ANALYSIS USING SWABSJune 2023June 2024Allow1200YesNo
18321542METHODS FOR DETECTING AAVMay 2023June 2024Allow1300NoNo
18313183MULTI-STEP KINETIC IMMUNOASSAY SYSTEMS AND METHODSMay 2023January 2024Allow910NoNo
18308813PEPTIDE QUANTITATION ASSAY FOR DIFFERENTIATING FULL-LENGTH HIGH MOLECULAR WEIGHT KININOGEN (HMWK) ANDCLEAVED HMWKApril 2023June 2024Allow1400YesNo
18139741SYNTHETIC HUMAN CELL MIMIC HYDROGEL PARTICLE FOR CYTOMETRIC OR COULTER DEVICEApril 2023October 2023Allow610NoNo
18307135AUTOSAMPLER SAMPLE AND SAMPLE RACK IDENTIFICATIONApril 2023January 2025Allow2010NoNo
18306176SENSORS AND SENSING METHODSApril 2023December 2024Abandon2010NoNo
18304915Screening Kit and Diagnosis System for Primary AldosteronismApril 2023August 2023Allow400NoNo
18301279METHODS FOR ANALYZING BODY FLUID PROTEOMEApril 2023June 2024Allow1420NoNo
18032020BINDING ASSAYS INVOLVING A PLURALITY OF SYNTHETIC COMPOUNDS, TARGETS, AND COUNTER TARGETSApril 2023November 2025Abandon3230YesNo
18123753Tandem Mass Tag Multiplexed Quantitation of Post-Translational Modifications of ProteinsMarch 2023June 2024Allow1500YesNo
18122010DEVICE AND METHODS FOR QUANTIFYING ANALYTES INTRODUCTIONMarch 2023August 2025Allow2940YesNo
18175066USE OF LC-MS/MS TO QUANTITATE PROTEIN BIOMARKERSFebruary 2023August 2024Allow1810YesNo
18112671DETECTION CHIP, USING METHOD FOR THE SAME, AND REACTION SYSTEMFebruary 2023December 2024Allow2210NoNo
18111336RAPID NATIVE SINGLE CELL MASS SPECTROMETRYFebruary 2023May 2024Allow1500NoNo
18165865ISOTYPING IMMUNOGLOBULINS USING ACCURATE MOLECULAR MASSFebruary 2023May 2024Allow1500NoNo
18154401METHODS FOR CHARACTERIZING DISULFIDE BONDSJanuary 2023January 2024Allow1200YesNo
18153738METHOD FOR EVALUATING DATA FROM MASS SPECTROMETRY, MASS SPECTROMETRY METHOD, AND MALDI-TOF MASS SPECTROMETERJanuary 2023September 2024Allow2010NoNo
18093939FILTRATION SAMPLING DEVICESJanuary 2023May 2023Allow511YesNo
18147248KIND OF METHOD FOR DETECTING SIALOGLYCOSYL CASEIN GLYCOMACROPEPTIDEDecember 2022December 2025Allow3610NoNo
18088946SYSTEM AND METHOD FOR PROTEIN CORONA SENSOR ARRAY FOR EARLY DETECTION OF DISEASESDecember 2022January 2024Allow1300YesNo
18145602METHODS FOR THE DETECTION AND TREATMENT OF PROSTATE CANCERDecember 2022February 2026Allow3700NoNo
18069458FORMULATION FOR TOTAL AND DIFFERENTIAL COUNTING OF LEUKOCYTES IN LIQUID MEDIUM AND METHOD OF MAKING AND USING SAMEDecember 2022July 2025Allow3100NoNo
18069502METHYLATION MARKERS AND TARGETED METHYLATION PROBE PANELDecember 2022March 2023Allow300NoNo
18079644Tracer AnalysisDecember 2022July 2024Allow1900NoNo
18063975RAPID IDENTIFICATION AND SEQUENCE ANALYSIS OF INTACT PROTEINS IN COMPLEX MIXTURESDecember 2022March 2025Allow2720YesNo
17928893AMINO-SUBSTITUTED CHROMENOQUINOLINE-BASED FLUORESCENT MARKER, AND PREPARATION AND USE THEREOFNovember 2022August 2025Allow3210NoNo
18059404METHOD FOR DISCRIMINATING A MICROORGANISMNovember 2022April 2024Allow1710NoNo
18070451COMPOUNDS FOR MARKING LIQUIDSNovember 2022February 2026Abandon3801NoNo
17927025METHOD AND APPARATUS FOR ANALYZING BIOCHIP IMAGE, COMPUTER DEVICE, AND STORAGE MEDIUMNovember 2022February 2026Allow3920NoNo
17991366REAGENT FOR MASS SPECTROMETRYNovember 2022February 2026Allow3920NoNo
17990360CYTOMETRIC DEVICE HEMATOLOGY REFERENCE COMPOSITIONNovember 2022April 2023Allow510NoNo
17975288Methods and Systems for Measuring Progesterone MetabolitesOctober 2022January 2026Abandon3910NoNo
17921165METHODS OF DETECTING UBE3A PROTEINOctober 2022July 2025Allow3200NoNo
17972535BTEX METABOLITES DERIVATIZATION KIT AND COMPOSITIONOctober 2022August 2024Allow2110NoNo
17919496ISOBARIC STABLE ISOTOPE-CONTAINING PHOSPHORYLATED PROTEIN LABELING REAGENT, AND PREPARATION METHOD AND APPLICATION THEREOFOctober 2022July 2025Allow3300NoNo
17960702METHODS OF CHARACTERIZING CONDENSATE-ASSOCIATED CHARACTERISTICS OF COMPOUNDS AND USES THEREOFOctober 2022October 2024Allow2510NoNo
17995452METHODS AND COMPOSITIONS TO DETERMINE THE QUALITY OF RED BLOOD CELL UNITSOctober 2022January 2026Abandon3910NoNo
17937170SYSTEMS AND METHODS FOR GLYCOPEPTIDE CONCENTRATION DETERMINATION, NORMALIZED ABUNDANCE DETERMINATION, AND LC/MS RUN SAMPLE PREPARATIONSeptember 2022September 2025Allow3511NoNo
17955214PEPCON PROTEOMICS STANDARDS AND METHODS OF USESeptember 2022June 2024Allow2020YesNo
17952304METHOD FOR CHARACTERIZING GRAPHENE ON PLATINUM SUBSTRATESeptember 2022June 2023Allow910NoNo
17762425METHODS AND SYSTEMS FOR DETECTING AND QUANTIFYING LARGE NUMBER OF MOLECULE BIOMARKERS FROM A BODY FLUID SAMPLESeptember 2022July 2025Allow4010NoNo
17910768BIOMARKERS FOR CLEAR CELL RENAL CELL CARCINOMASeptember 2022March 2026Allow4210NoNo
17930340METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATIONSeptember 2022June 2024Allow2130YesNo
17939760Optics Collection and Detection System and MethodSeptember 2022April 2024Allow1910NoNo
17930324METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATIONSeptember 2022March 2024Abandon1820YesNo
17903229Magnetic Selector And Systems Incorporating SameSeptember 2022September 2025Allow3610NoNo
17929369Automated Method For Performing An AssaySeptember 2022July 2024Allow2310NoNo
17929350Fluidic Test CassetteSeptember 2022March 2024Allow1800NoNo
17823360METHOD OF USING CHEMICAL TAGS TO IMPROVE THE IDENTIFICATION, QUANTIFICATION AND SPATIAL LOCALIZATION OF COMPONENTS IN A SAMPLEAugust 2022February 2024Allow1700NoNo
17802250CANCER DIAGNOSIS USING RAMAN SIGNAL OF URINEAugust 2022August 2025Allow3610YesNo
17887532DEVICE AND METHOD FOR COMPREHENSIVE CHARACTERIZATION, ANALYSIS, HETERO-GENITY AND PURITY QUANTIFICATION OF EXTRACELLULAR VESICLESAugust 2022September 2025Allow3700NoNo
17797284METHOD FOR ASSISTING DETECTION OF NON-ALCOHOLIC STEATOHEPATITISAugust 2022December 2025Allow4011YesNo
17875765AMINO ACID ANALYSIS METHODJuly 2022September 2025Allow3710NoNo
17862990NOVEL PHOTOCLEAVABLE MASS-TAGS FOR MULTIPLEXED MASS SPECTROMETRIC IMAGING OF TISSUES USING BIOMOLECULAR PROBESJuly 2022November 2023Allow1610YesNo
17608285DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDERS ASSOCIATED WITH ALTERED METABOLIC PATHWAYSJune 2022February 2026Abandon5210NoNo
17841098METHOD TO CORRECT ION SOURCE INEFFICIENCIES MAKES SAMPLE-TO-SAMPLE NORMALIZATION POSSIBLEJune 2022January 2024Allow1900YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner XU, XIAOYUN.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
57
Examiner Affirmed
36
(63.2%)
Examiner Reversed
21
(36.8%)
Reversal Percentile
58.1%
Higher than average

What This Means

With a 36.8% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
122
Allowed After Appeal Filing
30
(24.6%)
Not Allowed After Appeal Filing
92
(75.4%)
Filing Benefit Percentile
33.4%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 24.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner XU, XIAOYUN - Prosecution Strategy Guide

Executive Summary

Examiner XU, XIAOYUN works in Art Unit 1797 and has examined 837 patent applications in our dataset. With an allowance rate of 65.1%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 34 months.

Allowance Patterns

Examiner XU, XIAOYUN's allowance rate of 65.1% places them in the 26% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by XU, XIAOYUN receive 2.26 office actions before reaching final disposition. This places the examiner in the 63% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by XU, XIAOYUN is 34 months. This places the examiner in the 42% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +28.5% benefit to allowance rate for applications examined by XU, XIAOYUN. This interview benefit is in the 76% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 24.1% of applications are subsequently allowed. This success rate is in the 35% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 17.0% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.9% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 39% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 49.1% of appeals filed. This is in the 14% percentile among all examiners. Of these withdrawals, 38.2% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.

Petition Practice

When applicants file petitions regarding this examiner's actions, 62.1% are granted (fully or in part). This grant rate is in the 67% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 2.9% of allowed cases (in the 79% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.7% of allowed cases (in the 58% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.